Neurodex at the Bio-Neuroscience Conference

Neurodex at the Bio-Neuroscience Conference

Showcasing Pioneering Diagnostic Technologies We proudly announce that Neurodex will play a significant role at the forthcoming Bio-Neuroscience Conference, highlighting our innovative diagnostic technologies for neurodegenerative diseases. Oded Biran, our distinguished SEO, will present our leading-edge work in developing blood-based biomarkers and leveraging cell-specific extracellular vesicles (exosomes) for precise diagnostics. About Our Innovations Neurodex is…

NeuroDex Announces Second Award from The Michael J. Fox Foundation

NeuroDex Announces Second Award from The Michael J. Fox Foundation

NATICK, MA, USA, October 31, 2023 /EINPresswire.com/ — NeuroDex, Inc. (“NeuroDex”, or the “Company”), announces that it has received a second grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to study “Neuronal extracellular vesicles blood-based biomarker for lysosomal function.” This award will enable NeuroDex to utilize its unique ExoSORT™ platform to develop an…

Neurodex to Participate in 2nd Annual AAEV Meeting: Exploring the Potential of Extracellular Vesicles

Neurodex to Participate in 2nd Annual AAEV Meeting: Exploring the Potential of Extracellular Vesicles

Introduction: Neurodex is pleased to announce its participation in the upcoming 2nd Annual Meeting hosted by the American Association of Extracellular Vesicles (AAEV). Set against the picturesque backdrop of Boston, MA, this event promises to gather esteemed experts in extracellular vesicle research. Neurodex is gearing up to share its latest insights into the study of…

NeuroDex’s Chief Scientific Officer, Dr. Erez Eitan to Speak on Groundbreaking Biomarker Research at ISEV Workshop

NeuroDex’s Chief Scientific Officer, Dr. Erez Eitan to Speak on Groundbreaking Biomarker Research at ISEV Workshop

We are delighted to announce that Dr. Erez Eitan, Chief Scientific Officer of NeuroDex, will speak at the upcoming International Society for Extracellular Vesicles (ISEV) Workshop titled “EV-based Biomarkers: Commercialization and Clinical Implementation.” Scheduled to take place in the picturesque city of Aalborg, Denmark, from October 12th to 14th, 2023, this workshop is set to…

Michael J. Fox Foundation Funds Research on a Potential Parkinson’s Biomarker

Michael J. Fox Foundation Funds Research on a Potential Parkinson’s Biomarker

Introduction:  Parkinson’s disease is a progressive neurological disorder affecting millions worldwide. It is characterized by tremors, stiffness, and impaired movement, among other symptoms. Despite decades of research, there is currently no cure for Parkinson’s disease, and limited treatment options are available to patients. However, recent advances in biomarker research offer hope for earlier detection and…

NeuroDex, Inc., Announces Award from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator

NeuroDex, Inc., Announces Award from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator

NATICK, MASSACHUSETTS, UNITED STATES OF AMERICA, March 28, 2023/EINPresswire.com/ — NeuroDex, Inc.’s approved application, titled “Clinical Validation of a Robust Blood Test Using Neuron-Derived Exosomes for Detection of Alpha-Synuclein/TDP43 Pathologies in Patients with Alzheimer’s Disease,” highlights NeuroDex, Inc.’s unique methodology for isolation and analysis of neuron-derived exosomes.NeuroDex, Inc. (“NeuroDex”, or the “Company”), announces that it has…

NeuroDex Presents Breakthrough Research on Exosomes for Neurodegenerative Disease Diagnosis at ‘Extracellular Vesicles: Friends and Foes II’ Congress

NeuroDex Presents Breakthrough Research on Exosomes for Neurodegenerative Disease Diagnosis at ‘Extracellular Vesicles: Friends and Foes II’ Congress

Neurodegenerative diseases Neurodegenerative diseases are a complex and growing public health concern. These conditions, including Alzheimer’s disease, Parkinson’s disease, and Lewy body dementia, can cause significant disability and reduced quality of life. Unfortunately, diagnosing these diseases can be challenging, with current diagnostic methods often requiring invasive procedures, such as brain imaging or lumbar puncture. Neurodex…

NeuroDex, Inc., Announces Award from The Michael J. Fox Foundation

NeuroDex, Inc., Announces Award from The Michael J. Fox Foundation

For application titled: “Blood Test for Parkinson’s Stratification based on Neuron and Oligodendrocyte Derived Extracellular Vesicles”NATICK, MASSACHUSETTS, UNITED STATES OF AMERICA, January 26, 2023 /EINPresswire.com/ — NeuroDex, Inc.(“NeuroDex”, or the “Company”), announces that it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to study, “Blood Test for Parkinson’s Stratification based on Neuron…